Scientists track rare eye disease to uncover clues for future treatments
NCT ID NCT05312736
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 46 people with gyrate atrophy, a rare genetic condition that causes vision loss, over 4 years. Researchers measure ornithine levels in the blood and track changes in the retina using eye scans and photos. The goal is to learn how the disease progresses under standard dietary care, which may help design future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHORIORETINAL DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423
Paris, 75012, France
-
Harvard Univ., Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, 02114, United States
-
Helsinki University Hospital
Helsinki, 00280, Finland
-
INRET Clínica e Centro de Pesquisa
Belo Horizonte, Minas Gerais, 30150-270, Brazil
-
Johns Hopkins University, Wilmer Eye Institute
Baltimore, Maryland, 21287, United States
-
Moorfields Eye Hospital
London, UK EC1V 2PD, United Kingdom
-
University of California San Francisco
San Francisco, California, 94158, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Toronto, Hospital for Sick Children
Toronto, Ontario, M5G0A4, Canada
-
University of Tuebingen, Centre for Ophthalmology
Tübingen, 72076, Germany
-
Vista Vision Eye Clinic
Brescia, 25123, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.